nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronabinol—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.453	0.52	CbGbCtD
Dronabinol—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.418	0.48	CbGbCtD
Dronabinol—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00989	0.09	CcSEcCtD
Dronabinol—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00833	0.0758	CcSEcCtD
Dronabinol—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00617	0.0561	CcSEcCtD
Dronabinol—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.006	0.0545	CcSEcCtD
Dronabinol—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00459	0.0418	CcSEcCtD
Dronabinol—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00365	0.0332	CcSEcCtD
Dronabinol—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00361	0.0329	CcSEcCtD
Dronabinol—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00325	0.0295	CcSEcCtD
Dronabinol—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00287	0.0261	CcSEcCtD
Dronabinol—Depression—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0213	CcSEcCtD
Dronabinol—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00226	0.0205	CcSEcCtD
Dronabinol—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00221	0.0201	CcSEcCtD
Dronabinol—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0193	CcSEcCtD
Dronabinol—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.0021	0.0191	CcSEcCtD
Dronabinol—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0173	CcSEcCtD
Dronabinol—Chills—Riluzole—amyotrophic lateral sclerosis	0.0019	0.0172	CcSEcCtD
Dronabinol—Tension—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0164	CcSEcCtD
Dronabinol—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0162	CcSEcCtD
Dronabinol—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0155	CcSEcCtD
Dronabinol—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0151	CcSEcCtD
Dronabinol—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00162	0.0148	CcSEcCtD
Dronabinol—Cough—Riluzole—amyotrophic lateral sclerosis	0.0016	0.0146	CcSEcCtD
Dronabinol—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0145	CcSEcCtD
Dronabinol—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0142	CcSEcCtD
Dronabinol—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0142	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0141	CcSEcCtD
Dronabinol—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0141	CcSEcCtD
Dronabinol—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00153	0.0139	CcSEcCtD
Dronabinol—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00151	0.0138	CcSEcCtD
Dronabinol—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0134	CcSEcCtD
Dronabinol—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00146	0.0133	CcSEcCtD
Dronabinol—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00146	0.0133	CcSEcCtD
Dronabinol—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0132	CcSEcCtD
Dronabinol—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00143	0.013	CcSEcCtD
Dronabinol—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0128	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0124	CcSEcCtD
Dronabinol—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00133	0.0121	CcSEcCtD
Dronabinol—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0119	CcSEcCtD
Dronabinol—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0118	CcSEcCtD
Dronabinol—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00124	0.0112	CcSEcCtD
Dronabinol—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0112	CcSEcCtD
Dronabinol—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0108	CcSEcCtD
Dronabinol—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0101	CcSEcCtD
Dronabinol—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00979	CcSEcCtD
Dronabinol—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00965	CcSEcCtD
Dronabinol—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00934	CcSEcCtD
Dronabinol—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000992	0.00902	CcSEcCtD
Dronabinol—Rash—Riluzole—amyotrophic lateral sclerosis	0.000946	0.0086	CcSEcCtD
Dronabinol—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000945	0.0086	CcSEcCtD
Dronabinol—Headache—Riluzole—amyotrophic lateral sclerosis	0.00094	0.00855	CcSEcCtD
Dronabinol—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	9.97e-05	0.00523	CbGpPWpGaD
Dronabinol—CNR1—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	9.93e-05	0.00521	CbGpPWpGaD
Dronabinol—CYP2A6—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	9.84e-05	0.00517	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	9.64e-05	0.00506	CbGpPWpGaD
Dronabinol—CYP1A1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.58e-05	0.00503	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	9.47e-05	0.00497	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	9.01e-05	0.00473	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	8.88e-05	0.00466	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	8.75e-05	0.00459	CbGpPWpGaD
Dronabinol—CYP1A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.67e-05	0.00455	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	8.66e-05	0.00455	CbGpPWpGaD
Dronabinol—ABCG2—HIF-2-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	8.55e-05	0.00449	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	8.23e-05	0.00432	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	8.07e-05	0.00424	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	8.06e-05	0.00423	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	8.01e-05	0.00421	CbGpPWpGaD
Dronabinol—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.84e-05	0.00411	CbGpPWpGaD
Dronabinol—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	7.66e-05	0.00402	CbGpPWpGaD
Dronabinol—CYP2A6—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	7.59e-05	0.00398	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	7.57e-05	0.00398	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.54e-05	0.00396	CbGpPWpGaD
Dronabinol—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.15e-05	0.00375	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	7.14e-05	0.00375	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	7.11e-05	0.00373	CbGpPWpGaD
Dronabinol—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	7.09e-05	0.00372	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	6.92e-05	0.00363	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	6.86e-05	0.0036	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	6.71e-05	0.00352	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	6.67e-05	0.0035	CbGpPWpGaD
Dronabinol—ABCG2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	6.62e-05	0.00348	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	6.59e-05	0.00346	CbGpPWpGaD
Dronabinol—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.47e-05	0.0034	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	6.29e-05	0.0033	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.14e-05	0.00322	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	6.1e-05	0.0032	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.07e-05	0.00319	CbGpPWpGaD
Dronabinol—CYP2A6—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	6.01e-05	0.00316	CbGpPWpGaD
Dronabinol—CYP2A6—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	5.94e-05	0.00312	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	5.91e-05	0.0031	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	5.77e-05	0.00303	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.68e-05	0.00298	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	5.61e-05	0.00294	CbGpPWpGaD
Dronabinol—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.51e-05	0.00289	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.46e-05	0.00287	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	5.43e-05	0.00285	CbGpPWpGaD
Dronabinol—CYP1A1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.4e-05	0.00283	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.34e-05	0.0028	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	5.31e-05	0.00279	CbGpPWpGaD
Dronabinol—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.21e-05	0.00273	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.19e-05	0.00272	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.08e-05	0.00267	CbGpPWpGaD
Dronabinol—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	5.03e-05	0.00264	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5e-05	0.00262	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.98e-05	0.00261	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.94e-05	0.00259	CbGpPWpGaD
Dronabinol—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	4.88e-05	0.00256	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	4.82e-05	0.00253	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	4.77e-05	0.0025	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	4.69e-05	0.00246	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.64e-05	0.00244	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	4.61e-05	0.00242	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.58e-05	0.0024	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.56e-05	0.00239	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	4.55e-05	0.00239	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.49e-05	0.00236	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	4.47e-05	0.00235	CbGpPWpGaD
Dronabinol—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.42e-05	0.00232	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	4.39e-05	0.00231	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	4.39e-05	0.00231	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.37e-05	0.00229	CbGpPWpGaD
Dronabinol—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.27e-05	0.00224	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.23e-05	0.00222	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.22e-05	0.00221	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.22e-05	0.00221	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	4.21e-05	0.00221	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.17e-05	0.00219	CbGpPWpGaD
Dronabinol—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.03e-05	0.00212	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	4.02e-05	0.00211	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	3.99e-05	0.00209	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	3.99e-05	0.00209	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.98e-05	0.00209	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.98e-05	0.00209	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.93e-05	0.00207	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.91e-05	0.00205	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.89e-05	0.00204	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.89e-05	0.00204	CbGpPWpGaD
Dronabinol—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.88e-05	0.00204	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	3.88e-05	0.00204	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.86e-05	0.00203	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	3.84e-05	0.00202	CbGpPWpGaD
Dronabinol—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.83e-05	0.00201	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.73e-05	0.00196	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.73e-05	0.00196	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.66e-05	0.00192	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	3.65e-05	0.00192	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.59e-05	0.00188	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.52e-05	0.00185	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.51e-05	0.00184	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.47e-05	0.00182	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.39e-05	0.00178	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.37e-05	0.00177	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.27e-05	0.00172	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	3.25e-05	0.00171	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.19e-05	0.00167	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	3.19e-05	0.00167	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	3.17e-05	0.00167	CbGpPWpGaD
Dronabinol—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.17e-05	0.00167	CbGpPWpGaD
Dronabinol—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.13e-05	0.00164	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.07e-05	0.00161	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	3.05e-05	0.0016	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3e-05	0.00157	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.99e-05	0.00157	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.97e-05	0.00156	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.97e-05	0.00156	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.93e-05	0.00154	CbGpPWpGaD
Dronabinol—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.89e-05	0.00152	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	2.88e-05	0.00151	CbGpPWpGaD
Dronabinol—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.85e-05	0.0015	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.78e-05	0.00146	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.77e-05	0.00145	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.74e-05	0.00144	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.73e-05	0.00143	CbGpPWpGaD
Dronabinol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.72e-05	0.00143	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.72e-05	0.00143	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.65e-05	0.00139	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.62e-05	0.00137	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.53e-05	0.00133	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.5e-05	0.00131	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.48e-05	0.0013	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.47e-05	0.0013	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.43e-05	0.00128	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.43e-05	0.00128	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.41e-05	0.00126	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.38e-05	0.00125	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.37e-05	0.00125	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.37e-05	0.00125	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.36e-05	0.00124	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.35e-05	0.00124	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.31e-05	0.00121	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.27e-05	0.00119	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.22e-05	0.00117	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	2.22e-05	0.00117	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.22e-05	0.00116	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.22e-05	0.00116	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.19e-05	0.00115	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.17e-05	0.00114	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	2.15e-05	0.00113	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	2.13e-05	0.00112	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.1e-05	0.0011	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.1e-05	0.0011	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.08e-05	0.00109	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.07e-05	0.00109	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.07e-05	0.00109	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.04e-05	0.00107	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	2.03e-05	0.00106	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.02e-05	0.00106	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	2.02e-05	0.00106	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	1.94e-05	0.00102	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.94e-05	0.00102	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.94e-05	0.00102	CbGpPWpGaD
Dronabinol—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.91e-05	0.001	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.9e-05	0.000996	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.89e-05	0.00099	CbGpPWpGaD
Dronabinol—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.88e-05	0.000988	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.88e-05	0.000985	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.82e-05	0.000957	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.78e-05	0.000934	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.77e-05	0.000931	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.76e-05	0.000923	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.75e-05	0.00092	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.72e-05	0.000901	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.66e-05	0.00087	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.63e-05	0.000855	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.6e-05	0.000842	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.6e-05	0.00084	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.6e-05	0.000839	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.57e-05	0.000824	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.5e-05	0.000789	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.48e-05	0.000779	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.48e-05	0.000775	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.46e-05	0.000768	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.46e-05	0.000768	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.37e-05	0.000719	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.37e-05	0.000719	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.34e-05	0.000702	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.33e-05	0.0007	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.33e-05	0.000699	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.3e-05	0.000683	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.24e-05	0.000653	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.23e-05	0.000648	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.23e-05	0.000647	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.23e-05	0.000646	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.22e-05	0.000638	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.2e-05	0.00063	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.17e-05	0.000614	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.16e-05	0.000611	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.16e-05	0.00061	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.13e-05	0.000591	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.12e-05	0.000589	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.12e-05	0.000588	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.1e-05	0.000575	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.06e-05	0.000555	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.05e-05	0.000549	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.02e-05	0.000536	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.01e-05	0.00053	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.01e-05	0.000528	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.86e-06	0.000518	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.8e-06	0.000514	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.42e-06	0.000494	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.22e-06	0.000484	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	9.21e-06	0.000483	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.01e-06	0.000473	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.9e-06	0.000467	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	8.79e-06	0.000461	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.65e-06	0.000454	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.4e-06	0.000441	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.18e-06	0.00043	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	8.02e-06	0.000421	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.9e-06	0.000415	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.72e-06	0.000405	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	7.41e-06	0.000389	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	7.4e-06	0.000388	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	7.12e-06	0.000374	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	6.73e-06	0.000353	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.63e-06	0.000348	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.32e-06	0.000332	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.1e-06	0.00032	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	6.07e-06	0.000319	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.76e-06	0.000302	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.43e-06	0.000285	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.3e-06	0.000278	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.08e-06	0.000267	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	5.02e-06	0.000263	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.99e-06	0.000262	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.95e-06	0.00026	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.88e-06	0.000256	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.87e-06	0.000256	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.61e-06	0.000242	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.55e-06	0.000239	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	4.1e-06	0.000215	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	4.01e-06	0.00021	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	3.74e-06	0.000196	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.44e-06	0.00018	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.26e-06	0.000171	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3e-06	0.000157	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.81e-06	0.000148	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.75e-06	0.000144	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.56e-06	0.000135	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.47e-06	0.00013	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.69e-06	8.88e-05	CbGpPWpGaD
